SER
insider transactionsSerina Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
+10.1K
10.1K buy · 0 sell
Net value · 30d
$17.7K
$17.7K in · $0 out
Sentiment · 30d
Net buying
100% buying · 0% selling
Open-market trades · 30d
2
10.1K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Director
$8.8K
5.0K sh · $1.77
Own +98%
-
Buy·P
Director
$8.9K
5.1K sh · $1.75
Own New
-
Grant·A
Steven A Ledger KEY
Chief Executive Officer
$19.5K
10.1K sh · $1.93
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Karen J Wilson | Buy P | 5.0K | $8.8K |
| Jun 11, 2026 | Karen J Wilson | Buy P | 5.1K | $8.9K |
| May 26, 2026 | Steven A Ledger KEY | Grant A | 10.1K | $19.5K |
About SER insider trading
This page tracks insider transactions for Serina Therapeutics, Inc. (SER) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.